BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2021 1:47:10 PM | Browse: 649 | Download: 1616
 |
Received |
|
2021-02-18 12:33 |
|
Peer-Review Started |
|
2021-02-18 12:40 |
|
First Decision by Editorial Office Director |
|
2021-03-16 05:45 |
|
Return for Revision |
|
2021-03-16 05:45 |
|
Revised |
|
2021-03-30 05:10 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-04-16 13:03 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-04-21 03:26 |
|
Articles in Press |
|
2021-04-21 03:26 |
|
Edit the Manuscript by Language Editor |
|
2021-05-05 11:00 |
|
Typeset the Manuscript |
|
2021-05-21 01:37 |
|
Publish the Manuscript Online |
|
2021-06-04 13:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
New perspectives on angiotensin-converting enzyme 2 and its related diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Li-Ping Liu, Xiao-Li Zhang and Jian Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81873861 |
| Key Grant of Research and Development in Hunan Province |
2020DK2002 |
|
| Corresponding Author |
Jian Li, PhD, Associate Professor, Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, No. 371 Tong Zhi Po Road
, Changsha 410013, Hunan Province, China. lijianyxy@hunnu.edu.cn |
| Key Words |
Angiotensin-converting enzyme 2; COVID-19; Salt; Renin-angiotensin-system inhibitors; Diabetes and cardiovascular disease; Renal and lung disease |
| Core Tip |
Angiotensin-converting enzyme 2 (ACE2) as the key cell receptor for severe acute respiratory syndrome coronavirus 2 virus has received widespread attention. This review will review the new perspectives on ACE2 and covers available information on the host regulative factors of ACE2 and discusses its role in a variety of pathophysiological conditions. This review will help us with a better understanding of ACE2’s biological function and its role in coronavirus disease 2019 infection and treatment. |
| Publish Date |
2021-06-04 13:47 |
| Citation |
Liu LP, Zhang XL, Li J. New perspectives on angiotensin-converting enzyme 2 and its related diseases. World J Diabetes 2021; 12(6): 839-854 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i6/839.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i6.839 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
